Germany
Japan
United Kingdom
China
purified SSB mouse monoclonal capture antibody, validated for Luminex assays
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Matched ELISA Pair | TA700523 |
Primary Antibodies
View as table Download
USD 494.00
2 Weeks
purified ESR1 biotinylated mouse monoclonal detection antibody, validated for Luminex assays
| Applications | ELISA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Biotin |
| Matched ELISA Pair | TA600545 |
USD 494.00
2 Weeks
purified ESR1 biotinylated mouse monoclonal detection antibody, validated for Luminex assays
| Applications | ELISA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Biotin |
| Matched ELISA Pair | TA600545 |
USD 494.00
2 Weeks
purified ESR1 biotinylated mouse monoclonal detection antibody, validated for Luminex assays
| Applications | ELISA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Biotin |
| Matched ELISA Pair | TA600545 |
USD 494.00
2 Weeks
CTNNB1 biotinylated mouse monoclonal detection antibody, validated for Luminex assays
| Applications | ELISA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Biotin |
| Matched ELISA Pair | TA600047 |
Active filters
Assay Platforms
- 96-well plate
Families
- Transcription Factors
Filter by
Category
Target Symbol
Reactivities
Applications
Antibody Hosts
Isotypes
Clonalities
Conjugates
Assay Types
Pathways
- Wnt signaling pathway (22)
- MAPK signaling pathway (20)
- Pathways in cancer (19)
- Colorectal cancer (15)
- ErbB signaling pathway (14)
- Jak-STAT signaling pathway (14)
- Focal adhesion (11)
- TGF-beta signaling pathway (10)
- Endometrial cancer (9)
- Thyroid cancer (9)
- Acute myeloid leukemia (8)
- Chronic myeloid leukemia (8)
- T cell receptor signaling pathway (8)
- Toll-like receptor signaling pathway (8)
- Maturity onset diabetes of the young (7)
- Notch signaling pathway (7)
- B cell receptor signaling pathway (6)
- Epithelial cell signaling in Helicobacter pylori infection (6)
- GnRH signaling pathway (6)
- Neurotrophin signaling pathway (6)
- Renal cell carcinoma (6)
- Systemic lupus erythematosus (6)
- Adherens junction (5)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (5)
- Basal cell carcinoma (5)
- Leukocyte transendothelial migration (5)
- Melanogenesis (5)
- Pathogenic Escherichia coli infection (5)
- Prostate cancer (5)
- Tight junction (5)
- Adipocytokine signaling pathway (4)
- Alzheimer's disease (4)
- Amyotrophic lateral sclerosis (ALS) (4)
- Apoptosis (4)
- Bladder cancer (4)
- Cell cycle (4)
- Cytokine-cytokine receptor interaction (4)
- Small cell lung cancer (4)
- Allograft rejection (2)
- Asthma (2)
- Dilated cardiomyopathy (2)
- Fc epsilon RI signaling pathway (2)
- Graft-versus-host disease (2)
- Hematopoietic cell lineage (2)
- Hypertrophic cardiomyopathy (HCM) (2)
- NOD-like receptor signaling pathway (2)
- Natural killer cell mediated cytotoxicity (2)
- RIG-I-like receptor signaling pathway (2)
- Type I diabetes mellitus (2)
- Type II diabetes mellitus (2)